Non-traumatic avascular necrosis of the femoral head (NONFH)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Simultaneously meet the diagnostic criteria for NONFH and the syndrome differentiation criteria; (2) Patients with at least one side of avascular necrosis of the femoral head at ARCO Stage II; (3) Age between 18-55 years, with a disease duration of no more than 1 year; (4) No clear history of hip joint trauma; (5) Cessation of steroid medications for at least 3 months; (6) Patients who have signed the informed consent form to participate in the study.
Exclusion criteria
Exclusion criteria: (1) The primary disease is severe and requires other treatments that may affect the results of this trial; (2) Participants who have received other new drug clinical trials within the past six months; (3) Patients currently using medications that affect lipid metabolism, anti-coagulation, or blood-activating therapies; (4) Pregnant or intending to become pregnant individuals, as well as lactating women; (5) Participants with a history of allergy to multiple medications or those with an allergic constitution; (6) Patients with mental disorders or substance abuse/dependence on psychoactive substances; (7) Patients with hepatic or renal insufficiency, or coagulation disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Imaging therapeutic effect score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hip Joint Pain Intensity;Hip Flexion Function;Walking Distance;Surgery rate; | — |
Countries
China
Contacts
Beijing University of Chinese Medicine Third Affiliated Hospital